IT1398282B1 - Composizione comprendente acido alfa-lipoico e carnosina per il trattamento della sindrome dell arto fantasma - Google Patents
Composizione comprendente acido alfa-lipoico e carnosina per il trattamento della sindrome dell arto fantasmaInfo
- Publication number
- IT1398282B1 IT1398282B1 ITMI2009A001377A ITMI20091377A IT1398282B1 IT 1398282 B1 IT1398282 B1 IT 1398282B1 IT MI2009A001377 A ITMI2009A001377 A IT MI2009A001377A IT MI20091377 A ITMI20091377 A IT MI20091377A IT 1398282 B1 IT1398282 B1 IT 1398282B1
- Authority
- IT
- Italy
- Prior art keywords
- arthus
- carnosine
- ghost
- syndrome
- treatment
- Prior art date
Links
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 title 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 title 1
- 108010087806 Carnosine Proteins 0.000 title 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 title 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 title 1
- 229940044199 carnosine Drugs 0.000 title 1
- 235000019136 lipoic acid Nutrition 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- 229960002663 thioctic acid Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2009A001377A IT1398282B1 (it) | 2009-07-30 | 2009-07-30 | Composizione comprendente acido alfa-lipoico e carnosina per il trattamento della sindrome dell arto fantasma |
| US13/387,883 US20120129781A1 (en) | 2009-07-30 | 2010-07-22 | Composition comprising alpha-lipoic acid and carnosine for treating the phantom limb syndrome |
| EP10742421.0A EP2459185B1 (en) | 2009-07-30 | 2010-07-22 | Composition comprising alpha-lipoic acid and carnosine for treating the phantom limb syndrome |
| PCT/EP2010/004479 WO2011012256A1 (en) | 2009-07-30 | 2010-07-22 | Composition comprising alpha-lipoic acid and carnosine for treating the phantom limb syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2009A001377A IT1398282B1 (it) | 2009-07-30 | 2009-07-30 | Composizione comprendente acido alfa-lipoico e carnosina per il trattamento della sindrome dell arto fantasma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI20091377A1 ITMI20091377A1 (it) | 2011-01-31 |
| IT1398282B1 true IT1398282B1 (it) | 2013-02-22 |
Family
ID=41683167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI2009A001377A IT1398282B1 (it) | 2009-07-30 | 2009-07-30 | Composizione comprendente acido alfa-lipoico e carnosina per il trattamento della sindrome dell arto fantasma |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20120129781A1 (it) |
| EP (1) | EP2459185B1 (it) |
| IT (1) | IT1398282B1 (it) |
| WO (1) | WO2011012256A1 (it) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117900A (en) * | 1999-09-27 | 2000-09-12 | Asta Medica Aktiengesellschaft | Use of retigabine for the treatment of neuropathic pain |
| US20060159743A1 (en) | 2001-10-25 | 2006-07-20 | Depomed, Inc. | Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
| ITMI20061522A1 (it) * | 2006-08-01 | 2008-02-02 | Difass S A | Composizione ad attivita' antiossidante ed antiglicante migliorata |
| JP2010516815A (ja) * | 2007-01-31 | 2010-05-20 | ヘラー， アダム | 疼痛の治療のための方法および組成物 |
-
2009
- 2009-07-30 IT ITMI2009A001377A patent/IT1398282B1/it active
-
2010
- 2010-07-22 EP EP10742421.0A patent/EP2459185B1/en active Active
- 2010-07-22 WO PCT/EP2010/004479 patent/WO2011012256A1/en active Application Filing
- 2010-07-22 US US13/387,883 patent/US20120129781A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2459185B1 (en) | 2013-11-27 |
| US20120129781A1 (en) | 2012-05-24 |
| EP2459185A1 (en) | 2012-06-06 |
| ITMI20091377A1 (it) | 2011-01-31 |
| WO2011012256A1 (en) | 2011-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201500196B (it) | Derivati dell'acido idrossammico | |
| ZA201308086B (en) | Derivatives of 1-anino-2-cyclopropylboronic acid | |
| ZA201109334B (en) | Dosage forms of apixaban | |
| SMT201600332B (it) | Composizioni e metodi per l’aumento dell’attivitàtelomerasica | |
| GB201000916D0 (en) | Treatment of biofilms | |
| EP2572730A4 (en) | PROCESS FOR PROPHYLAXIS OR TREATMENT OF METABOLIC SYNDROME | |
| FI20095278A0 (fi) | Ksylonihapon valmistus | |
| IL228630A0 (en) | Compounds for the treatment of the metabolic syndrome | |
| ZA201201802B (en) | Composition for treatment of cxcl8-mediated lung inflammation | |
| HK1166371A1 (en) | Prediction of response to platinum-based therapy | |
| SMT201600156B (it) | Trattamento dell’osteoartrite | |
| IT1403587B1 (it) | Composizione per il trattamento di disordini metabolici | |
| HK1257401A1 (zh) | 用於治療糖尿病和相關病症的方法和組合物 | |
| FI20105638A0 (fi) | Kivipinnoitteen valmistus | |
| EP2416803A4 (en) | NEW METHODS OF TREATING INFLAMMATORY DISEASES | |
| SMT201500119B (it) | Nuova composizione per il trattamento della trombocitemia essenziale | |
| IL223385B (en) | Treatment of inflammatory disorders | |
| IT1398282B1 (it) | Composizione comprendente acido alfa-lipoico e carnosina per il trattamento della sindrome dell arto fantasma | |
| EP2536688A4 (en) | STABLE DOSAGE FORMS OF LEVOMILNACIPRAN | |
| TWM389539U (en) | Outward-expanding handrail structure of wheelchair | |
| EP2356986A4 (en) | COMPOSITION FOR METABOLIC SYNDROME TREATMENT | |
| IT1398281B1 (it) | Composizione comprendente acido alfa-lipoico e carnosina per il trattamento della sindrome cpps, della sindrome cp e/o della vulvodinia | |
| TWM370404U (en) | Structure of compound massage set | |
| GB0802904D0 (en) | Treatment of metabolic syndrome | |
| TWM400995U (en) | Modified structure of substrate cassette |